Immune Therapy Shows Response and Remission in Crohn’s Patients, Study Finds

Immune Therapy Shows Response and Remission in Crohn’s Patients, Study Finds
Patients with Crohn’s disease benefit from treatment with a new platform of immunotherapies designed to restore the body’s innate immune system, a study has found. The announcement was made by Qu Biologics, the company behind the Site Specific Immunomodulators (SSIs). SSIs are a platform of immunotherapies obtained from components of bacteria and are designed to treat cancer and other immune-related

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *